Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Income from Continuing Operations: 2009-2024

Historic Income from Continuing Operations for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to -$6.4 million.

  • Cumberland Pharmaceuticals' Income from Continuing Operations fell 26.81% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.3 million, marking a year-over-year increase of 69.22%. This contributed to the annual value of -$6.4 million for FY2024, which is 1.78% down from last year.
  • As of FY2024, Cumberland Pharmaceuticals' Income from Continuing Operations stood at -$6.4 million, which was down 1.78% from -$6.3 million recorded in FY2023.
  • In the past 5 years, Cumberland Pharmaceuticals' Income from Continuing Operations registered a high of -$5.6 million during FY2021, and its lowest value of -$6.6 million during FY2020.
  • Moreover, its 3-year median value for Income from Continuing Operations was -$6.3 million (2023), whereas its average is -$6.1 million.
  • Per our database at Business Quant, Cumberland Pharmaceuticals' Income from Continuing Operations grew by 28.07% in 2020 and then dropped by 12.05% in 2023.
  • Cumberland Pharmaceuticals' Income from Continuing Operations (Yearly) stood at -$6.6 million in 2020, then climbed by 15.53% to -$5.6 million in 2021, then fell by 0.95% to -$5.7 million in 2022, then declined by 12.05% to -$6.3 million in 2023, then dropped by 1.78% to -$6.4 million in 2024.